Tag: clinical outcomes
-
Does lowering Lp(a) actually cut cardiovascular events? The outcome trials — HORIZON, OCEAN(a) and ACCLAIM — and why the first readout is still not in
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, and not medical advice. The 30-second version What. Earlier parts of this series established that Lp(a) is causal (Mendelian randomization), genetically fixed, and now pharmacologically lowerable by 80–90%+ with siRNA/ASO/oral agents. But biomarker…
Uthando Nethemba 